| RS1032858847 |
TUB
|
Health Risk |
Pathogenic |
— |
| RS1032873228 |
MSH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary nonpolyposis colorectal neoplasms, Hereditary cancer-predisposing syndrome |
| RS1032877391 |
CHD7
|
Health Risk |
Conflicting classifications of pathogenicity |
CHARGE syndrome, CHD7-related disorder |
| RS1032878925 |
CLCN7
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteopetrosis, Osteopetrosis |
| RS1032879686 |
ITGA2B
|
Health Risk |
Pathogenic |
Glanzmann thrombasthenia, Glanzmann thrombasthenia |
| RS1032930719 |
POLG
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive sclerosing poliodystrophy, Progressive external ophthalmoplegia with mitochondrial DNA deletions |
| RS1032938979 |
COL4A3
|
Health Risk |
Conflicting classifications of pathogenicity |
Autosomal dominant Alport syndrome, Hematuria |
| RS1032992615 |
L1CAM
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Inborn genetic diseases |
| RS1033054565 |
ZNF469
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, Cardiovascular phenotype |
| RS1033059668 |
ANK2
|
Health Risk |
Conflicting classifications of pathogenicity |
Long QT syndrome, Cardiovascular phenotype |
| RS1033092772 |
BCOR
|
Health Risk |
Conflicting classifications of pathogenicity |
Oculofaciocardiodental syndrome, Inborn genetic diseases |
| RS1033093801 |
CAPN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Autosomal recessive spastic paraplegia type 76, Hereditary spastic paraplegia 11 |
| RS1033108057 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1033112015 |
SLC39A4
|
Health Risk |
Likely pathogenic |
— |
| RS1033126561 |
GANAB
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Polycystic kidney disease 3 with or without polycystic liver disease |
| RS1033188876 |
SACS
|
Health Risk |
Conflicting classifications of pathogenicity |
Charlevoix-Saguenay spastic ataxia, Spastic paraplegia |
| RS1033194020 |
CEBPA
|
Health Risk |
Conflicting classifications of pathogenicity |
Acute myeloid leukemia, Inborn genetic diseases |
| RS1033207881 |
IDH3A
|
Health Risk |
Likely pathogenic |
— |
| RS1033213070 |
COG5
|
Health Risk |
Conflicting classifications of pathogenicity |
COG5-congenital disorder of glycosylation, Inborn genetic diseases |
| RS1033214914 |
CACNA1A
|
Health Risk |
Conflicting classifications of pathogenicity |
Episodic ataxia type 2, Developmental and epileptic encephalopathy |
| RS1033220280 |
RBM20
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1DD, Cardiovascular phenotype |
| RS1033229812 |
SON
|
Health Risk |
Pathogenic |
— |
| RS1033235740 |
ATP7B
|
Health Risk |
Pathogenic/Likely pathogenic |
Wilson disease, Wilson disease |
| RS1033251181 |
MAGEL2
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, MAGEL2-related disorder |
| RS1033263382 |
COL1A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Osteogenesis imperfecta type I, Cardiovascular phenotype |
| RS1033270809 |
MYO15A
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1033313360 |
IDUA
|
Health Risk |
Pathogenic/Likely pathogenic |
Hurler syndrome, Mucopolysaccharidosis type 1 |
| RS1033319065 |
PLEKHG5
|
Health Risk |
Conflicting classifications of pathogenicity |
Neuronopathy, distal hereditary motor |
| RS1033335294 |
LAMB3
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1033348008 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1033353171 |
ERCC6
|
Health Risk |
Likely pathogenic |
— |
| RS1033402019 |
TERT
|
Health Risk |
Conflicting classifications of pathogenicity |
Dyskeratosis congenita, autosomal dominant 2 |
| RS1033427343 |
NF1
|
Health Risk |
Conflicting classifications of pathogenicity |
Neurofibromatosis, type 1 |
| RS1033442580 |
LAMP2
|
Health Risk |
Conflicting classifications of pathogenicity |
Danon disease, Cardiovascular phenotype |
| RS1033444972 |
ERCC2
|
Health Risk |
Pathogenic |
— |
| RS1033463168 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1033476644 |
JPH2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy, Cardiovascular phenotype |
| RS1033477931 |
PGM3
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 23, Immunodeficiency 23 |
| RS1033490064 |
ABCB11
|
Health Risk |
Conflicting classifications of pathogenicity |
Progressive familial intrahepatic cholestasis type 2, Progressive familial intrahepatic cholestasis type 2 |
| RS1033533679 |
MYOC
|
Health Risk |
Likely pathogenic |
Glaucoma 1, open angle |
| RS1033545876 |
COL12A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ullrich congenital muscular dystrophy 2, Bethlem myopathy 2 |
| RS1033577592 |
ATP2B1
|
Health Risk |
Pathogenic |
Neurodevelopmental disorder, Intellectual developmental disorder |
| RS1033586067 |
MET
|
Health Risk |
Conflicting classifications of pathogenicity |
Renal cell carcinoma, Papillary renal cell carcinoma type 1 |
| RS1033594764 |
CEP290
|
Health Risk |
Pathogenic |
Joubert syndrome, Meckel-Gruber syndrome |
| RS1033630760 |
KLC4
|
Health Risk |
Likely pathogenic |
— |
| RS1033649515 |
HSD17B4
|
Health Risk |
Conflicting classifications of pathogenicity |
Bifunctional peroxisomal enzyme deficiency, Perrault syndrome |
| RS1033651300 |
BAP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, BAP1-related tumor predisposition syndrome |
| RS1033653237 |
MTO1
|
Health Risk |
Likely pathogenic |
Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency, Mitochondrial hypertrophic cardiomyopathy with lactic acidosis due to MTO1 deficiency |
| RS1033681137 |
KCNV2
|
Health Risk |
Pathogenic |
— |
| RS1033693138 |
SRGAP3
|
Health Risk |
Likely pathogenic |
Moyamoya angiopathy, Moyamoya angiopathy |
| RS1033708386 |
VSX2
|
Health Risk |
Pathogenic |
Isolated microphthalmia 2, Isolated microphthalmia 2 |
| RS1033725987 |
TSC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 1, Hereditary cancer-predisposing syndrome |
| RS1033726905 |
PHKA1
|
Health Risk |
Conflicting classifications of pathogenicity |
Glycogen storage disease IXd, Glycogen storage disease IXd |
| RS1033730754 |
ELAC2
|
Health Risk |
Likely pathogenic |
Combined oxidative phosphorylation defect type 17, Combined oxidative phosphorylation defect type 17 |
| RS1033739107 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1033747538 |
MFRP
|
Health Risk |
Pathogenic |
Isolated microphthalmia 5, Isolated microphthalmia 5 |
| RS1033749344 |
MSH6
|
Health Risk |
Pathogenic/Likely pathogenic |
Lynch syndrome, Hereditary cancer-predisposing syndrome |
| RS1033766338 |
SDCCAG8
|
Health Risk |
Conflicting classifications of pathogenicity |
Bardet-Biedl syndrome 16, Senior-Loken syndrome 7 |
| RS1033803342 |
PCDH15
|
Health Risk |
Pathogenic |
— |
| RS1033836182 |
COL5A2
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial thoracic aortic aneurysm and aortic dissection, Ehlers-Danlos syndrome |
| RS1033887530 |
CAPN1
|
Health Risk |
Likely pathogenic |
Autosomal recessive spastic paraplegia type 76, Autosomal recessive spastic paraplegia type 76 |
| RS1033911248 |
NEB
|
Health Risk |
Conflicting classifications of pathogenicity |
Nemaline myopathy 2, Inborn genetic diseases |
| RS1033915282 |
PEX1
|
Health Risk |
Conflicting classifications of pathogenicity |
Zellweger spectrum disorders, Zellweger spectrum disorders |
| RS1033918125 |
MYLK
|
Health Risk |
Conflicting classifications of pathogenicity |
Aortic aneurysm, familial thoracic 7 |
| RS1033920857 |
PROM1
|
Health Risk |
Conflicting classifications of pathogenicity |
Retinal dystrophy, Retinitis pigmentosa 41 |
| RS1033921573 |
LAMA3
|
Health Risk |
Pathogenic |
— |
| RS1033941048 |
MEFV
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial Mediterranean fever, autosomal dominant |
| RS1033946108 |
UFM1
|
Health Risk |
Likely pathogenic |
Leukodystrophy, hypomyelinating |
| RS1033990351 |
DSP
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 8, Arrhythmogenic cardiomyopathy with wooly hair and keratoderma |
| RS1033998490 |
ATL1
|
Health Risk |
Likely pathogenic |
— |
| RS1034078411 |
HPS1
|
Health Risk |
Pathogenic |
— |
| RS1034084415 |
EGFR
|
Health Risk |
Likely pathogenic |
EGFR-related lung cancer, EGFR-related lung cancer |
| RS1034099077 |
CSGALNACT1
|
Health Risk |
Pathogenic |
Skeletal dysplasia, mild |
| RS1034113927 |
APC
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial adenomatous polyposis 1, Hereditary cancer-predisposing syndrome |
| RS1034133545 |
LAMA2
|
Health Risk |
Pathogenic/Likely pathogenic |
Merosin deficient congenital muscular dystrophy, Muscular dystrophy |
| RS1034155331 |
GCDH
|
Health Risk |
Pathogenic |
Glutaric aciduria, type 1 |
| RS1034185619 |
GALT
|
Health Risk |
Conflicting classifications of pathogenicity |
Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase, Deficiency of UDPglucose-hexose-1-phosphate uridylyltransferase |
| RS1034207896 |
HBB
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1034235291 |
ATM
|
Health Risk |
Conflicting classifications of pathogenicity |
Ataxia-telangiectasia syndrome, Hereditary cancer-predisposing syndrome |
| RS1034243338 |
COL9A1
|
Health Risk |
Pathogenic |
— |
| RS1034268466 |
TAB2
|
Health Risk |
Pathogenic |
TAB2-related disorder, TAB2-related disorder |
| RS1034284582 |
BRWD3
|
Health Risk |
Conflicting classifications of pathogenicity |
Intellectual disability, X-linked 93 |
| RS1034291686 |
NTHL1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, NTHL1-related disorder |
| RS1034327724 |
RSPH4A
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia, Primary ciliary dyskinesia 11 |
| RS1034350880 |
PPP1R12A
|
Health Risk |
Likely pathogenic |
— |
| RS1034356533 |
TRDN
|
Health Risk |
Conflicting classifications of pathogenicity |
Catecholaminergic polymorphic ventricular tachycardia 1, Catecholaminergic polymorphic ventricular tachycardia 1 |
| RS1034391830 |
HMBS
|
Health Risk |
Pathogenic |
— |
| RS1034395084 |
TTLL5
|
Health Risk |
Pathogenic |
— |
| RS1034395178 |
LZTR1
|
Health Risk |
Pathogenic |
Noonan syndrome 2, Cardiovascular phenotype |
| RS1034436638 |
COL5A1
|
Health Risk |
Conflicting classifications of pathogenicity |
Ehlers-Danlos syndrome, classic type |
| RS1034459470 |
MED13L
|
Health Risk |
Conflicting classifications of pathogenicity |
Dextro-looped transposition of the great arteries, Inborn genetic diseases |
| RS1034464770 |
GRM6
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Inborn genetic diseases |
| RS1034483511 |
FLNC
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 26, Distal myopathy with posterior leg and anterior hand involvement |
| RS1034487400 |
CSF3R
|
Health Risk |
Likely pathogenic |
— |
| RS1034492140 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Dilated cardiomyopathy 1G |
| RS1034508175 |
DYNC1H1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2O, Charcot-Marie-Tooth disease axonal type 2O |
| RS1034528249 |
QDPR
|
Health Risk |
Pathogenic/Likely pathogenic |
Dihydropteridine reductase deficiency, Dihydropteridine reductase deficiency |
| RS1034532622 |
ZNF687
|
Health Risk |
Conflicting classifications of pathogenicity |
— |
| RS1034545913 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Fanconi anemia complementation group J |
| RS1034551306 |
BRIP1
|
Health Risk |
Conflicting classifications of pathogenicity |
Familial cancer of breast, Fanconi anemia complementation group J |